当前位置:首页 - 行情中心 - 云南白药(000538) - 财务分析

云南白药

(000538)

  

流通市值:1053.22亿  总市值:1060.03亿
流通股本:17.73亿   总股本:17.84亿

云南白药(000538)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润36.45亿元,每股收益2.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益4050097.36万元,未分配利润1849989.95万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产5453549.07万元,负债1403451.71万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入21,257,102,896.0210,841,237,721.2940,033,300,814.7229,915,155,069.84
营业总成本17,836,286,155.078,751,171,876.2635,206,797,286.525,480,753,830.78
其他经营收益
营业利润4,220,316,255.722,255,305,450.435,711,621,822.285,010,889,055.01
利润总额4,231,871,841.792,255,981,3955,684,719,663.995,013,251,270.61
净利润3,644,599,967.941,927,511,203.494,767,072,360.284,329,700,490.03
每股收益
其他综合收益4,613,102.15-122,538.7-13,441,329.34-5,079,332.38
综合收益总额3,649,213,070.091,927,388,664.794,753,631,030.944,324,621,157.65
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计35,074,714,780.1435,436,604,060.534,150,663,141.0837,400,015,187.52
非流动资产:
非流动资产合计19,460,775,923.9318,816,422,257.1418,763,518,191.9718,212,503,942.66
资产总计54,535,490,704.0754,253,026,317.6452,914,181,333.0555,612,519,130.18
流动负债:
流动负债合计12,813,745,845.5912,240,342,494.1812,858,491,395.2413,903,888,177.76
非流动负债:
非流动负债合计1,220,771,222.611,217,714,657.531,189,605,375.541,165,244,401.55
负债合计14,034,517,068.213,458,057,151.7114,048,096,770.7815,069,132,579.31
所有者权益(或股东权益):
归属于母公司股东权益合计40,406,601,054.1540,768,110,417.8738,831,946,424.5140,522,380,082.77
股东权益合计40,500,973,635.8740,794,969,165.9338,866,084,562.2740,543,386,550.87
负债和股东权益合计54,535,490,704.0754,253,026,317.6452,914,181,333.0555,612,519,130.18
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计24,002,572,014.210,830,762,784.1643,880,006,829.3732,872,412,099.37
经营活动现金流出小计20,041,384,811.4310,117,165,224.5139,583,003,687.128,799,273,354.03
经营活动产生的现金流量净额3,961,187,202.77713,597,559.654,297,003,142.274,073,138,745.34
投资活动产生的现金流量:
投资活动现金流入小计2,531,420,210.39946,127,434.078,019,213,440.175,125,866,466.37
投资活动现金流出小计3,486,707,527.531,012,765,741.899,218,214,486.646,283,661,079.58
投资活动产生的现金流量净额-955,287,317.14-66,638,307.82-1,199,001,046.47-1,157,794,613.21
筹资活动产生的现金流量:
筹资活动现金流入小计133,715,072.0316,000,439.391,962,072,461.451,538,345,214.75
筹资活动现金流出小计2,717,556,950.46487,209,760.468,939,807,625.335,200,040,692.26
筹资活动产生的现金流量净额-2,583,841,878.43-471,209,321.07-6,977,735,163.88-3,661,695,477.51
汇率变动对现金及现金等价物的影响-5,088,619.221,032,499.263,497,174.93-2,606,865.09
现金及现金等价物净增加额416,969,387.98176,782,430.02-3,876,235,893.15-748,958,210.47
期末现金及现金等价物余额10,692,498,963.3210,452,312,005.3610,275,529,575.3413,402,807,258.02
补充资料:
现金及现金等价物的净增加额416,969,387.98--3,876,235,893.15-
最新报告期:2025-09-02
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华泰证券代雯,唐庆雷,张云逸2.953.273.612025-09-02
中金公司张琎,朱言音,杨一正2.933.22--2025-09-01
中金公司张琎,朱言音,杨一正2.933.22--2025-08-18
光大证券王明瑞,黄素青2.953.283.642025-08-03
TOP↑